Physician profile
Daniel J Steier
NPI 1265582266
$1,412.60
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $626 · 2020: $119 · 2021: $655 · 2022: $13.44.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $192.36 | 2019-2021 | |
| Amarin Pharma, INC. | $167.56 | 2019-2021 | |
| Boston Scientific Corporation | $164.31 | 2019-2022 | |
| Astrazeneca Pharmaceuticals Lp | $109.79 | 2019 | |
| Amgen INC. | $109.00 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $95.40 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $88.61 | 2019-2021 | |
| Pfizer INC. | $57.90 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $52.92 | 2021 | |
| Astellas Pharma US INC | $51.83 | 2019-2021 | |
| Lilly USA, LLC | $38.15 | 2021 | |
| Abbvie INC. | $35.73 | 2019-2021 | |
| Glaxosmithkline, LLC. | $33.87 | 2021 | |
| Gilead Sciences, INC. | $32.78 | 2019 | |
| Allergan, INC. | $32.56 | 2019-2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insulet Corporation | $28.48 | 2019-2020 | |
| Daiichi Sankyo INC. | $18.77 | 2021 | |
| Novartis Pharmaceuticals Corporation | $14.31 | 2021 | |
| Antares Pharma, INC. | $13.79 | 2019 | |
| Nalpropion Pharmaceuticals LLC | $13.20 | 2019 | |
| Nestle Healthcare Nutrition INC. | $13.02 | 2021 | |
| Janssen Pharmaceuticals, INC | $12.56 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.27 | 2020 | |
| Circassia INC. | $12.23 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $11.20 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Steier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.